Company: PFSA
Filing Date: 2025-09-17
Form Type: S-1/A
Source: 0001213900-25-088333
Chunk: 342

Company: Profusa, Inc.
Filing Date: 2025-09-17
Form: S-1/A
Chunk 342
---
 “Proxy Statement/Prospectus”), including, among other things, the adoption of the Merger Agreement and approval of the transactions contemplated thereby, including the merger of Merger Sub with and into Profusa, with Profusa continuing as the surviving corporation and as a wholly -ownedsubsidiary of the Company (the “Merger”), and the issuance of the Company’s common stock as consideration thereunder (together with the other transactions contemplated by the Merger Agreement, the “Business Combination”). On July 11, 2025 (the “Closing Date”), the Company closed the Business Combination with Profusa. As a result of the Business Combination, the Company owns 100% of the outstanding common stock of Profusa. In connection with the closing of the Business Combination, the Company changed its name from “NorthView Acquisition Corporation” to “Profusa, Inc.” Business Prior to the Business Combination On December 22, 2021, the Company consummated its Initial Public Offering (“IPO”) of 18,975,000units (the “Units”), which included 2,475,000Units issued pursuant to the full exercise of the over -allotmentoption granted to the underwriters. Each Unit consists of oneshare of common stock of the Company, par value $ 0.0001per share, oneright (the “Rights”), and one -halfof one redeemable warrant of the Company (the “Warrants”). Each Right entitles the holder thereof to receive one -tenth(1/10) of oneshare of common stock. Each Warrant entitles the holder thereof to purchase oneshare of common stock for $ 11.50per share, subject to adjustment. The Units were sold at a price of $ 10.00per Unit, generating gross proceeds to the Company of $ 189,750,000. Simultaneously with the closing of the IPO, the Company completed the private sale of an aggregate of 7,347,500warrants (the “Private Placement Warrants”), which included 697,500Private Placement Warrants issued pursuant to the full exercise of the over -allotmentoption granted to the underwriters, to NorthView Sponsor I, LLC (“the Sponsor”), I -BankersSecurities, Inc., and Dawson James Securities, Inc. at a purchase price of $ 1.00per Private Placement Warrant, generating gross proceeds to the Company of $ 7,347,500, which is discussed in